BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Jul 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-07-02

Reporting Person: Pierce David A (EVP,Pres MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-02	Common Stock	M	5000.0000	$7.1600	Acquired	29201.0000	Direct
2018-07-02	Common Stock	S	5000.0000	$32.4237	Disposed	24201.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-02	Stock Option (Right to Buy)	$7.1600	M	5000.0000	Disposed	2021-02-28	Common Stock (5000.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant.